Contact
searchSearch
HMP Global

Respiratory Syncytial Virus Topic Center

Featured Article

News
Long-Term Effectiveness of RSV Vaccine Declines Over Two Seasons, VHA Study Finds
11/25/2025
Grace Taylor, MS, MA
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health...
11/25/2025
Pharmacy Learning Network
News
RSV Vaccination Rates Remain Low Among US Veterans
11/19/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus...
11/19/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Shows Strong Safety Profile in Adults, Global Analysis Finds
11/14/2025
Grace Taylor, MS, MA
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds...
11/14/2025
Pharmacy Learning Network
News
Primary Care Providers Drive RSV Vaccine Uptake Among Older Adults
11/12/2025
Grace Taylor, MS, MA
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey...
11/12/2025
Pharmacy Learning Network
News
RSV Poses Significant Threat to Patients With Systemic Autoimmune Rheumatic Diseases
10/31/2025
Grace Taylor, MS, MA
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune...
10/31/2025
Pharmacy Learning Network
News
Dual RSV and Influenza Vaccination Reduces Health Care Utilization and Costs Among Older Adults
10/31/2025
Juliet Gallagher
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study...
10/31/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Proves Highly Effective Against Severe RSV in Older Adults
10/29/2025
Grace Taylor, MS, MA
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser...
10/29/2025
Pharmacy Learning Network
News
RSV Poses Sixfold Higher Hospitalization and Death Risk for Long-Term Care Residents
10/21/2025
Lisa Kuhns, PhD, MD
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term...
10/21/2025
Pharmacy Learning Network
News
RSV Vaccines Cut Hospitalizations in Older Adults but Show Gaps in High-Risk Groups
09/29/2025
Grace Taylor, MS, MA
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds...
09/29/2025
Pharmacy Learning Network
News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Comorbidities Drive ICU Admission and Mortality in RSV and HMPV Among Older Adults
07/16/2025
Grace Taylor, MS, MA
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals...
07/16/2025
Pharmacy Learning Network

Newsfeed

News
Long-Term Effectiveness of RSV Vaccine Declines Over Two Seasons, VHA Study Finds
11/25/2025
Grace Taylor, MS, MA
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health...
11/25/2025
Pharmacy Learning Network
News
RSV Vaccination Rates Remain Low Among US Veterans
11/19/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus...
11/19/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Shows Strong Safety Profile in Adults, Global Analysis Finds
11/14/2025
Grace Taylor, MS, MA
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds...
11/14/2025
Pharmacy Learning Network
News
Primary Care Providers Drive RSV Vaccine Uptake Among Older Adults
11/12/2025
Grace Taylor, MS, MA
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey...
11/12/2025
Pharmacy Learning Network
News
RSV Poses Significant Threat to Patients With Systemic Autoimmune Rheumatic Diseases
10/31/2025
Grace Taylor, MS, MA
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune...
10/31/2025
Pharmacy Learning Network
News
Dual RSV and Influenza Vaccination Reduces Health Care Utilization and Costs Among Older Adults
10/31/2025
Juliet Gallagher
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study...
10/31/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Proves Highly Effective Against Severe RSV in Older Adults
10/29/2025
Grace Taylor, MS, MA
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser...
10/29/2025
Pharmacy Learning Network
News
RSV Poses Sixfold Higher Hospitalization and Death Risk for Long-Term Care Residents
10/21/2025
Lisa Kuhns, PhD, MD
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term...
10/21/2025
Pharmacy Learning Network
News
RSV Vaccines Cut Hospitalizations in Older Adults but Show Gaps in High-Risk Groups
09/29/2025
Grace Taylor, MS, MA
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds...
09/29/2025
Pharmacy Learning Network
News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Bottles of Children’s Ibuprofen Recalled Nationwide Over Contamination Concerns
03/19/2026
Grace Taylor, MS, MA
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of...
03/19/2026
Pharmacy Learning Network
News
Apotex Recalls Brimonidine/Timolol Ophthalmic Solution Over Sterility Concerns
03/19/2026
Grace Taylor, MS, MA
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled...
03/19/2026
Pharmacy Learning Network
PharmLaw
Wholesale Pharmaceutical Executives Sentenced in $92 Million Drug Diversion Scheme
03/18/2026
Grace Taylor, MS, MA
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical...
03/18/2026
Pharmacy Learning Network
News
Midodrine Hydrochloride Under Class II Recall Due to Inadequately Sealed Blister Packaging
03/12/2026
Hannah Musick
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is...
03/12/2026
Pharmacy Learning Network
News
Teva Metoprolol Succinate Tablets Recalled for Failed Dissolution Specifications
03/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug...
03/12/2026
Pharmacy Learning Network
News
Cipla Nilotinib Capsules Recalled for Stability Specification Failures
03/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class III recall for select lots of Cipla’s nilotinib capsules after stability testing identified out-of-specification appearance and description results.
The US Food and Drug Administration (FDA) has issued a Class III recall for select lots of Cipla’s nilotinib capsules after stability testing identified out-of-specification appearance and description results.
The US Food and Drug...
03/12/2026
Pharmacy Learning Network
PharmLaw
Novo Nordisk Drops Patent Suit as Hims & Hers Shifts to FDA-Approved Semaglutide Products
03/11/2026
Hannah Musick
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its...
03/11/2026
Pharmacy Learning Network
News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Nationwide Recall of Isotretinoin Capsules Issued Over Dissolution Failure
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use